Phaeohyphomycoses (brown-black moulds)

Essentials of Clinical Mycology: Second Edition

Volumn , Issue , 2011, Pages 305-317

  Perfect, John R ^a   Alexander, Barbara D ^a   Schell, Wiley A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862866268     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-6640-7_17     Document Type: Chapter

References (132)

1. Ajello L, Georg LK, Steigbigel RT. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia. 1974;66:490-8.
2. Fader RC, McGinnis MR. Infections caused by dematiaceous fungi: chromoblastomycosis and phaeohyphomycosis. Infect Dis Clin North Am. 1988;2:925-38.
3. Rinaldi MG. Phaeohyphomycosis. Dermatol Clin. 1996;14:142-53.
4. de Hoog GS, Guarroe J, Gene J, Figueras MJ. Atlas of Clinical Fungi. 2nd ed. Utrecht: Centaalbureau voor Schimmelcultures; 2000.
5. Schell WA. Dematiaceous Hyphomycetes. In: Howard DH, editor. Fungi Pathogenic for Humans and Animals, revised and expanded. 2nd ed. New York: Marcel Dekker; 2003. p. 565-636.
6. Schell WA, Salkin IF, McGinnis JR. Bipolaris, Exophiala, Scedosporium, Sporothrix and other dematiaceous fungi. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of Clinical Microbiology. 8th ed. Washington: American Society for Microbiology; 2003. p. 1820-47.
7. Ferguson BJ, Barnes L, Bernstein JM, et al. Geographical variation in allergic fungal rhinosinusitis. Otolaryngol Clin North Am. 2000;33:441-9.
8. MMWR. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States, July- November, 2002. Morbidity and Mortality Weekly Report MMWR 2002;51:1109-1112.
9. Rao CY, Pachucki C, Cali S, et al. Contaminated product water as the source of Phialemonium curvatum bloodstream infection among patients undergoing hemodialysis. Infect Control Hosp Epidemiol. 2009;30:840-7.
10. Welty KE, Perfect JR. Cutaneous mycoses in solid organ transplants. Clin Adv Treat Fungal Infect. 1991;2:1-23.
11. Vukmir RB, Kusne S, Linden P, et al. Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava in a liver transplant recipient. Clin Infect Dis. 1994;19:714-9.
12. Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24:369-74.
13. Clancy CJ, Wingard JR, Nguyen MH. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol. 2000;38:169-75.
14. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care center. Clin Infect Dis. 2009;48:1033-41.
15. del Palacio-Hernanz A, Moore MK, Campbell CK, del Palacio- Perez-Medel A, del Castillo-Cantero R. Infection of the central nervous system by Rhinocladiella atrovirens in a patient with acquired immunodeficiency syndrome. J Med Vet Mycol. 1989;27:127-30.
16. Perfect JR, Schell WA, Rinaldi MG. Uncommon invasive fungal pathogens in the acquired immunodeficiency syndrome. J Med Vet Mycol. 1993;31:175-9.
17. Marriott DJ, Wong KH, Aznar E. Scytalidium dimidiatum and Lecythophora hoffmannii: unusual causes of fungal infections in a patient with AIDS. J Clin Microbiol. 1997;35:2949-52.
18. Dixon DM, Polak A, Conner GW. Mel-mutants of Wangiella dermatitidis in mice: evaluation of multiple mouse and fungal strains. J Med Vet Mycol. 1989;27:335-41.
19. Dixon DM, Migliozzi J, Cooper Jr. CR, Solis O, Breslin B, Szaniszlo PJ. Melanized and non-melanized multicellular form mutants of Wangiella dermatitidis in mice: Mortality and histopathology studies. Mycoses. 1992;35:17-21.
20. Feng B, Wang X, Hauser M, et al. Molecular cloning and characterization of WdPks1, a gene involved in dihydroxynaphthalene melanin biosynthesis and virulence in Wangiella (Exophiala) dermatitidis. Infect Immun. 2001;69:1781-94.
21. Schnitzler N, Peltroche-Llacsahuanga H, Bestier N, Zundorf J, Lutticken R, Haase G. Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils. Infect Immun. 1999;67:94-101.
22. Wang Z, Zheng L, Liu H, Wang Q, Hauser M, Kauffman S, et al. WdChs2p, a class I chitin synthase, together with WdChs3p class III contributes to virulence in Wangiella (Exophiala) dermatitidis. Infect Immun. 2001;69:7517-26.
23. Ibrahim-Granet O, de Bievre C, Jendoubi M. Immunochemical characterisation of antigens and growth inhibition of Fonsecaea pedrosoi by species-specific IgG. J Med Microbiol. 1988;26:217-22.
24. Fuchs J, Pecher S. Partial suppression of cell mediated immunity in chromoblastomycosis. Mycopathologia. 1992;119:73-6.
25. Perfect JR, Schell WA. The newer fungal opportunists are coming. Clin Infect Dis. 1996;22:112-8.
26. Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis. 2001;14:679-84.
27. Benedict LA, Kusne S, Torre-Cisneros J, Hunt SJ. Primary cutaneous fungal infection after solid-organ transplantation. Clin Infect Dis. 1993;15:17-21.
28. Vartian CV, Shlaes DM, Padhye AA, Ajello L. Wangiella dermatitidis endocarditis in an intravenous drug user. Am J Med. 1985;78:703-7.
29. Walz R, Bianchin M, Chaves ML, Cerski MR, Severo LC, Londero AT. Cerebral phaeohyphomycosis caused by Cladophialophora bantiana in a Brazilian drug abuser. J Med Vet Mycol. 1997;35:427-31.
30. Kaufman SM. Curvularia endocarditis following cardiac surgery. Am J Clin Pathol. 1971;56:466-70.
31. Pauzner R, Goldschmied-Reouven A, Hay I, Vared Z, Ziskind Z, Hassin N, et al. Phaeohyphomycosis following cardiac surgery: case report and review of serious infection due to Bipolaris and Exserohilum species. Clin Infect Dis. 1997;25:921-3.
32. Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis. 2002;34:467-76.
33. Kerr C, Perfect JR, Gallis HA, Craven PC, Drutz DJ, Shelburne J, et al. Fungal peritonitis in patients on chronic ambulatory peritoneal dialysis. Ann Intern Med. 1983;99:334-7.
34. Schwartz RA. Superficial fungal infections. Lancet. 2004; 364:1173-82.
35. Ronan SG, Vzoaru I, Nadimpalli V, Guitart J, Manaligod JR. Primary cutaneous phaeohyphomycosis: report of seven cases. J Cutan Pathol. 1993;20:223-8.
36. Forster RK, Rebell G, Wilson LA. Dematiaceous fungal keratitis: clinical isolates and management. Br J Ophthalmol. 1975;59:372-6.
37. Schell WA. Oculomycoses caused by dematiaceous fungi. Proceedings of the VI International Conference on the Mycoses. Pan American Health Organization, Washington: Scientific Publication No. 470. 1986, pp105-109.
38. McGinnis MR, Rinaldi MG, Winn RE. Emerging agents of phaeohyphomycosis: Pathogenic species of Bipolaris and Exserohilum. J Clin Microbiol. 1986;24:250-9.
39. Thomas RA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16:730-97.
40. Wilhemus KR, Jones DB. Curvularia keratitis. Trans Am Ophthalmol Soc. 2001;99:111-30.
41. Sudduth EJ, Crumbley AJ, Farrar WE. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis. 1992;15:639-44.
42. Schell WA. Histopathology of fungal rhinosinusitis. Otolaryngol Clin N Am. 2000;33:251-76.
43. Corey JR, Delsupeke KG, Ferguson BJ. Allergic fungal sinusitis: Allergic, infectious or both? Otolaryngol Head Neck Surg. 1995;113:110-9.
44. Washburn RG, Kennedy DW, Begley MG, Henderson DK, Bennett JE. Chronic fungal sinusitis in apparently normal hosts. Medicine (Baltimore). 1988;67:231-47.
45. MacMillan III RH, Cooper PH, Body BA, Mills AS. Allergic fungal sinusitis due to Curvularia lunata. Hum Pathol. 1987;18:960-4.
46. Gourley DS, Whisman BA, Jorgensen NL, Martin ME, Reid MJ. Allergic Bipolaris sinusitis: clinical and immunopathologic characteristics. J Allergy Clin Immunol. 1990;85:583-91.
47. Schell WA. Unusual fungal pathogens in fungal sinusitis. Otolaryngol Clin North Am. 2000;33:367-73.
48. Palaoglu S, Sau A, Yalcinlar Y, Scheithauer BW. Cerebral phaeohyphomycosis. Neurosurgery. 1993;33:894-7.
49. Horre R, de Hoog GS. Primary cerebral infections by melanized fungi: A review. In: de Horre GS, editor. Studies in Mycology #43: Ecology and Evolution of Black Yeasts and Their Relatives. Baarn: Centralbureau Voor Schimmel; 1999. p. 176-93.
50. Rohwedder JJ, Simmons JL, Colfer H, Gatmaitan B. Disseminated Curvularia lunata infection in a football player. Arch Intern Med. 1979;139:940-1.
51. Flanagan KL, Bryceson AD. Disseminated infection due to Bipolaris australiensis in a young immunocompetent man: case report and review. Clin Infect Dis. 1997;25:311-3.
52. Khan JA, Hussain ST, Hasan S. Disseminated Bipolaris infection in an immunocompetent host: An atypical presentation. J Am Med Assoc. 2002;50:68-71.
53. Li DM, de Hoog GS. Cerebral phaeohyphomycosis: At cure at what lengths? Lancet Infect Dis. 2009;9:376-83.
54. Marr KA, Carter RA, Crippa RA, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909-17.
55. Marco de Lucas E, Sádaba P, Lastra García-Barón P, et al. Cerebral scedosporiosis: An emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation. Eur Radiol. 2005;16:496-502.
56. Tintelnot K, Wagner N, Seibold M, de Hoog GS, Horré R. Re-identification of clinical isolates of the Pseudallescheria boydiicomplex involved in near-drowning. Mycoses. 2008;51 Suppl 3:11-6.
57. Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37:221-9.
58. Schell WA. New aspects of emerging fungal pathogens. A multifaceted challenge. Clin Lab Med. 1995;15:365-87.
59. Schell WA, Perfect JR. Fatal, disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol. 1996;34:1333-6.
60. Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol. 1998;109:45-54.
61. Bennett JE, Bonner H, Jennings AE, Lopez RI. Chronic meningitis caused by Cladosporium trichoides. Am J Clin Pathol. 1973;59:398-407.
62. Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: A review of cases presented between 1999 and 2004. Mycoses. 2004;47:4-13.
63. Georg LK, Bierer BW, Cooke WB. Encephalitis in turkey poults due to a new fungus species. Sabouraudia. 1964;3:239-44.
64. Sides EH, Benson JD, Padhye AA. Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type. J Med Vet Mycol. 1991;29:317-22.
65. Kanj SS, Amr SS, Roberts GD. Ramichloridium mackenziei brain abscess: report of two cases and review of the literature. Med Mycol. 2001;39:97-102.
66. Watanabe S, Hironaga M. An atypical isolate of Scedoporium apiospermum from a purulent meningitis in man. Sabouraudia. 1981;19:209-15.
67. Yoo D, Lee WHS, Kwon-Chung KJ. Brain abscess due to Pseudallescheria boydii associated with primary non-Hodgkin's lymphoma of the central nervous system: A case report and literature review. Rev Infect Dis. 1985;7:272-7.
68. Dworzack DL, Clark RB, Padgett PJ. New causes of pneumonia, meningitis, and disseminated infections associated with immersion. Infect Control Hosp Epidemiol. 1987;1:615-33.
69. Perfect JR, Durack DT. Pathogenesis and management of fungal infections in the central nervous system. In: Scheld WM, Whitley RJ, Durack DT, editors. Infections of the Central Nervous System. New York: Lippincott-Raven; 1997. p. pp 21-738.
70. Sigler L. Miscellaneous opportunistic fungi: Microascaceae and other ascomycetes, hyphomycetes, coelomycetes and basidiomycetes. In: Howard DH, editor. Fungi Pathogenic for Humans and Animals, revised and expanded. 2nd ed. New York: Marcel Dekker; 2003. p. 637-76.
71. Viviani MA, Tortorano AM, Laria G, Giannetti A, Bignotti G. Two new cases of cutaneous alternariosis with a review of the literature. Mycopathologia. 1986;96:3-12.
72. Wiest PM, Wiese K, Jacobs MR, et al. Alternaria infection in a patient with acquired immune deficiency syndrome: case report and review of invasive Alternaria infections. Rev Infect Dis. 1987;9:799-803.
73. Pastor FJ, Guarro J. Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect. 2008;14:734-46.
74. Morrison VA, Weisdorf DJ. Alternaria: A sinonasal pathogen of immunocompressed hosts. Clin Infect Dis. 1993;16:265-70.
75. Rolston KV, Hopfer RL, Larson DL. Infections caused by Drechslera species: case report and review of the literature. Rev Infect Dis. 1985;7:525-9.
76. Adam RD, Paquin ML, Peterson EA. Phaeohyphomycosis caused by the fungal genera Bipolaris and Exserohilum. A report of 9 cases and review of the literature. Medicine (Baltimore). 1986;65:203-17.
77. Karim M, Sheikh H, Alam M, Sheikh Y. Disseminated Bipolaris infection in an asthmatic patient: case report. Clin Infect Dis. 1993;17:248-53.
78. Latham RH. Bipolaris spicifera meningitis complicating a neurosurgical procedure. Scand J Infect Dis. 2000;32:102-3.
79. Schell WA, Esterre P. Chromoblastomycosis. In: Merz WG, Hay R, editors. Topley and Wilson's Microbiology and Microbial Infections, Medical Mycology. 10th ed. London: Edward Arnold; 2005. p. 356-66.
80. Monte SMD, Hutchens GM. Disseminated Curvularia infection. Arch Pathol Lab Med. 1985;109:872-4.
81. Yau YC, de Nanassy J, Summerbell RC, Matlow AG, Richardson SE. Fungal sternal wound infection due to Curvularia lunata in a neonate with congenital heart disease: case report and review. Clin Infect Dis. 1994;19:735-40.
82. Fernandez M, Noyola DE, Rosemann SN, Edwards MS. Cutaneous phaeohyphomycosis caused by Curvularia lunata and a review of Curvularia infections in pediatrics. Pediatr Infect Dis J. 1999; 18:727-31.
83. Janaki C, Sentamilselvi G, Janaki VR, Devesh S, Ajithados K. Eumycetoma due to Curvularia lunata. Mycoses. 1999;2:345-6.
84. Carter E, Boudreaux C. Fatal cerebral phaeohyphomycosis due to Curvaularia lunata in an immunocompetent host. J Clin Microbiol. 2004;42:5419-23.
85. Tintelnot K, de Hoog GS, Thomas E, Steudel WI, Huebner K, Seeliger HPR. Cerebral phaeohyphomycosis caused by an Exophiala species. Mycoses. 1991;34:239-44.
86. Gold WL, Vellend H, Salit IE, Campbell I, Summerbell R, Rinaldi M, et al. Successful treatment of systemic and local infections due to Exophiala species. Clin Infect Dis. 1994;19:339-41.
87. Morris A, Schell WA, McDonagh D, Chafee S, Perfect JR. Fonsecaea pedrosoi pneumonia and Emericella nidulans cerebral abscesses in a bone marrow transplant patient. Clin Infect Dis. 1995;21:1346-8.
88. Najafzadeh MJ, Gueidan C, Badali H, Gerrits van den Ende AHG, Lian X, de Hoog GS. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. Med Mycol. 2009;47:17-25.
89. Ndiaye B, Develoux M, Dieng MT, Kane A, Ndir O, Raphenon G, et al. Current report of eumycetoma in Senegal: report of 109 cases. J Mycol Med. 2000;10:140-4.
90. Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: Proposal of two new species. J Clin Microbiol. 2005;43:4930-42.
91. Gilgado F, Cano J, Gene J, Sutton DA, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol. 2008;46:766-71.
92. Berenguer J, Diaz-Mediavilla J, Urra D, Munoz P. Central nervous system infection caused by Pseudallescheria boydii: case report and review. Rev Infect Dis. 1989;11:890-6.
93. Berenguer J, Rodriquez-Tudela JL, Richard C. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Medicine (Baltimore). 1997;76:256-65.
94. Maertens J, Lagrou K, Deweerdt H. Disseminated infection by Scedosporium profilicans: An emerging fatality among haematology patients. Case report and review. Ann Hematol 2001; 79:340-344.
95. Hiruma M, Kawada A, Ohata H, Ohnishi Y, Takahashi H, Yamazaki M, et al. Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses. 1993;36:1-7.
96. Matsumoto T, Matsuda T, McGinnis MR, Ajello L. Clinical and mycological spectra of Wangiella dermatitidis infection. Mycoses. 1992;36:145-55.
97. Husain S, Munoz P, Forrest G, Alexander BD, Somani J, Brennan K, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis. 2005;40:89-99.
98. Nucci M, Akiti T, Barreiros G, Silveira F, Revankar SG, Sutton DA, et al. Nosocomial fungemia due to Exophiala jeanselmei var. jeanselmei and Rhinocladiella species newly described causes of bloodstream infection. J Clin Microbiol. 2001;39:514-8.
99. Gerrits van den Ende AHG, de Hoog GS. Variability and molecular diagnostics of the neyurotropic species Cladophialophoraa bantiana. Studies in Mycology 43: Ecology and Evolution of Black Yeasts and Their Relatives. Baarn/Delft, The Netherlands: Centralbureau Voor Schimmel. 1999, pp 151-162.
100. Heinz T, Serafin DB, Schell WA, Perfect JR. Soft tissue fungal infections: Surgical management of 12 immunocompromised patients. Plast Reconstr Surg. 1996;97:1391-9.
101. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: A review of 101 cases. Clin Infect Dis. 2004;38:206-16.
102. Shimosaka S, Waga S. Cerebral chromoblastomycosis complicated by meningitis and multiple fungal aneurysms after resection of a granuloma. Case Report. J Neurosurg. 1983;59:158-61.
103. Ferguson BJ. Fungus balls of the paranasal sinuses. Otolaryngol Clin North Am. 2000;33:389-98.
104. McGinnis MR, Pasarell RL, Sutton DA. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother. 1997;41:1821-34.
105. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole UK 109, 496 against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol. 1998;36:198-202.
106. Espinel-Ingroff A. A comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK 0991 L-743, 872 and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol. 1998;36:2950-6.
107. McGinnis MR, Pasarell L. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol. 1998;36:243-6.
108. Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol. 1990;23:577-86.
109. Fothergill AW, Rinaldi MG, Sutton DA. Antifungal susceptibility testing of Exophiala spp.: A head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole. Med Mycol. 2009;47:41-3.
110. Perfect JR, Marr KA, Walsh TJ, et al. Voriconazole treatment for less common, emerging or refractory fungal infections. Clin Infect Dis. 2003;36:112-1131.
111. Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop São Paulo. 2005; 47:339-46.
112. Negroni R, Helou SH, Petri N, Robles Am, Arechavala A, Bianchi MH. Case study: Posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera. Clin Infect Dis. 2004;38:e15-20.
113. Al-Abdely HM, Najvar L, Bocanegra R, et al. SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum (Ramichloridium mackenziei). Antimicrob Agents Chemother. 2000;44:1159-62.
114. Heath Ch, Slavin MA, Sorrell TC, et al. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect. 2009;15:689-93.
115. Walsh TJ, Lutsar I, Driscoll T, Dupont B, Rhoden M, Gharamani P, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J. 2002;21:240-8.
116. Troke P, Aquirrebengoak K, Arteaga C, Ellis D, Heath CH, Lutsar I, et al. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother. 2008;52:1743-50.
117. Rodriques-Tudela JL, Berenguer J, Guarro J, Kantarcioglu AS, Horre R, de Hoog GS, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol. 2009;47:359-70.
118. Caira M, Girmenia C, Valentini CG, et al. Scedosporiosis in patients with acute leukemia; a retrospective multicenter report. Haematologica. 2008;93:104-10.
119. Queiroz-Telles F, Esterre P, Perez-Blanco M, Vital RG, Salgado CG, Bonifaz A. Chromoblastomycosis: An overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009;47:3-15.
120. Del Poeta M, Schell WA, Perfect JR. In vitro antifungal activity of pneumocandin L-743, 872 against a variety of clinically important moulds. Antimicrob Agents Chemother. 1997;41:1835-6.
121. Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12, 052 fungal isolates: review of the literature. Rev Iberoam Micol. 2003; 20:121-36.
122. Meletiadis J, Mouton JW, Rodriquez-Tudela JL. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother. 2000;44:470-2.
123. Ferguson BJ. What role do systemic corticosteroids, immunotherapy, and antifungal drugs play in the therapy of allergic fungal rhinosinusitis? Arch Otolaryngol Head Neck Surg. 1998;124:1174-8.
124. CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard-Second Edition. CLSI document M38-A2. Wayne: Clincal and Laboratory Standards Institute. 2008.
125. Espinel-Ingroff A, Fothergill A, Ghannoum M, et al. Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M38 document) for amphotericin B, itraconazole, posaconazole, and voriconazole. J Clin Microbiol. 2005; 43:5243-6.
126. Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavagthu E, Ostrosky-Zeichner L, Pfaller M, et al. Quality control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against Molds. J Clin Microbiol. 2007;45:2180-2.
127. Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, Ellis D, Pfaller MA, Messer S, et al. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol. 2007;45:1811-20.
128. Fuste FJ, Ajello L, Threlkeld R, Henry Jr. JE. Drechslera hawaiiensis: causative agent of a fatal fungal meningo-encephalitis. Sabouraudia. 1973;11:59-63.
129. Seaworth BJ, Kwon-Chung CJ, Hamilton JD, Perfect JR. Brain abscess caused by a variety of Cladosporium trichoides. Am J Clin Pathol. 1983;79:747-52.
130. Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis. 1989;11:515-25.
131. Sekhon AS, Galbraith J, Mielke BW, Garg AK, Sheehan G. Cerebral phaeohyphomycosis caused by Xylohypha bantiana, with a review of the literature. Eur J Epidemiol. 1992;8:387-90.
132. Greer KE, Gross GP, Cooper PH, Harding SA. Cystic chromomycosis due to Wangiella dermatitidis. Arch Dermatol. 1979; 115:1433-4.